Created in 2018 (Belgium), Handl Therapeutics own 359 sister brands and 2214 competing brands. Handl Therapeutics's notoriety arose from exemplary management which optimizes product quality and client satisfaction, which in turn generate financial performance, and therefore, stock performance. Being a Popular brand online is assessed based on the evolution of worldwide Web searches over the last five years.

Handl Therapeutics is a brand of UCB (UCB) Popularity

Buy UCB share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
The following interest graph for Handl Therapeutics shows the evolution of worldwide Web searches in the last five years. The graph shows the evolution of Handl Therapeutics search rates over time, with a value of 100 indicating the month when it was highest.
Evolution of interest in the search “Handl Therapeutics” (Google Trends)
Sources: Google Trends and Allbrands.markets
Compare the 5-year Web notoriety graph with the 5-year market price graph:
Notoriety -> Market prices